Insider Transactions in Q3 2023 at Monopar Therapeutics (MNPR)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2023
|
Christopher M Starr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,533
+9.79%
|
-
|
|
Sep 30
2023
|
Kim R Tsuchimoto Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,444
-8.31%
|
$0
$0.62 P/Share
|
|
Sep 30
2023
|
Kim R Tsuchimoto Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,956
+19.37%
|
-
|
|
Sep 30
2023
|
Chandler Robinson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,172
-5.29%
|
$0
$0.62 P/Share
|
|
Sep 30
2023
|
Chandler Robinson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,474
+15.29%
|
-
|
|
Sep 30
2023
|
Andrew Cittadine Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,624
-5.41%
|
$0
$0.62 P/Share
|
|
Sep 30
2023
|
Andrew Cittadine Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,953
+15.57%
|
-
|
|
Sep 30
2023
|
Raymond Anderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,533
+9.43%
|
-
|
|
Sep 30
2023
|
Michael J Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,533
+1.07%
|
-
|
|
Sep 30
2023
|
Arthur J Klausner Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,533
+8.21%
|
-
|